Senior Engineer
Recursion
Senior Engineer
Recursion
Data-driven drug discovery platform leveraging datasets
The Impact You’ll Make
Help shift Recursion from periodic scans to continuous, risk-driven exposure management. You’ll build multi-agent systems that take vulnerabilities from discovery to verified closure, with approval gates, audit trails, and rollback built in. You’ll replace static CVSS scores with prioritization based on reachability, attack paths, business criticality, and live exploit intelligence, so engineering teams can focus on what’s actually exploitable. By integrating remediation into ticketing and CI/CD and partnering with Engineering and IT to make secure-by-default the norm, you’ll shrink our attack surface and speed up fixes where risk is highest, helping Recursion keep decoding biology with confidence.
In this role, you will:
The Team You’ll Join
You will join a growing Information Security team at Recursion, focused on enabling Recursion to decode biology by providing world class secure technology services that are designed and fit for purpose. You'll collaborate with your teammates and across departments to ensure that IAM systems support the organization's broader business objectives while maintaining the highest standards of security.
The Experience You’ll Need
Working Location & Compensation:
This is a remote position based in the United States. We ask that remote employees commit to regular on-site visits for routine work and departmental events.
At Recursion, we believe that every employee should be compensated fairly. Based on the skills, experience, and qualifications needed for this role, the estimated annual base salary range is: $134,200–$180,600. In addition to base salary, this role is eligible for an annual bonus, equity compensation, and a comprehensive benefits package.
#LI-DNI
The Values We Hope You Share:
Our values underpin the employee experience at Recursion. They are the character and personality of the company demonstrated through how we communicate, support one another, spend our time, make decisions, and celebrate collectively.
More About Recursion
Recursion (NASDAQ: RXRX) is a clinical-stage TechBio company decoding biology to radically improve lives. Recursion is advancing a portfolio of differentiated investigational medicines across its wholly owned and partnered pipeline in oncology, rare disease, neuroscience, immunology, and other therapeutic areas with significant unmet need. Enabling its mission is the Recursion OS, an AI-native, end-to-end drug discovery and development platform integrating biology, chemistry, and clinical development into a unified intelligence system. Powered by proprietary multimodal data, purpose-built AI models, and bilingual teams fluent in both science and AI, the Recursion OS is designed to translate complex science into medicines that matter — faster, better, and at scale — for patients who are waiting.
Recursion’s platform infrastructure is anchored in Salt Lake City, Utah and Milton Park, Oxfordshire, where its automated biology and chemistry laboratories generate proprietary data at industrial scale. Recursion also maintains offices in New York, Montréal, and London, three global hubs for talent and leadership at the intersection of AI and scientific innovation. Learn more at www.recursion.com, or connect on X and LinkedIn.
Recursion is an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, age, disability, veteran status, or any other characteristic protected under applicable federal, state, local, or provincial human rights legislation.
Accommodations are available on request for candidates taking part in all aspects of the selection process.
Recursion uses a data-driven platform to speed up drug discovery in TechBio by combining large biological and patient datasets with wet-lab experiments. It runs tens of thousands of experiments weekly to profile genes and compounds across many cell types, and processes results on its BioHive 1 supercomputer to map billions of gene–compound relationships. This approach lets Recursion identify potential drug candidates by turning experimental data into actionable insights, and it collaborates through strategic partnerships with pharma companies, labs, and healthcare providers rather than pursuing traditional in-house discovery alone. Its goal is to decode biology at scale and translate findings into new medicines that help patients.
Explore more opportunities at Recursion